All new biological products need to be characterized prior to inclusion in a clinical trial. The physiochemical characterization of the product includes a range of analytical and molecular methods to elucidate the primary and secondary structure.

We combine CRL and the world's leading protein and biological characteristic analysis of companies like drugs Protagen Protein Services (PPS), according to customers demand flexibility in the use of the technical capabilities to support a comprehensive characterization program for inclusion in regulatory filings in the United States, Europe and Japan to support early clinical development programs.